Market Cap 144.82B
Revenue (ttm) 62.58B
Net Income (ttm) 7.77B
EPS (ttm) N/A
PE Ratio 8.14
Forward PE 8.43
Profit Margin 12.42%
Debt to Equity Ratio 0.71
Volume 47,058,300
Avg Vol 43,589,973
Day's Range N/A - N/A
Shares Out 5.70B
Stochastic %K 100%
Beta 0.34
Analysts Sell
Price Target $28.70

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
TraderDaKing
TraderDaKing Aug. 6 at 4:49 PM
$ELTP $PFE $JNJ $MRNA $LLY Who is doing a deal with Elite?? SequestOx (ELI-200) is an investigational, abuse-deterrent opioid product developed by Elite Pharmaceuticals containing a combination of oxycodone hydrochloride and sequestered naltrexone for managing moderate to severe pain. How SequestOx WorksNormal Use: Taken orally as intended, the opioid agonist (oxycodone) releases for pain relief while the antagonist (naltrexone) stays locked inside and passes through the body unreleased.Tampering: If the capsule or beads are crushed, chewed, or dissolved, the naltrexone releases.Blockade: The released naltrexone blocks the euphoric high of oxycodone by binding to brain receptors, which deters recreational abuse. https://elitepharma.com/ Roaring Kitty?
0 · Reply
Brice149
Brice149 Aug. 6 at 4:26 PM
$PFE Lots of good if you look for it. The 20 and the 200 day ma are both moving up. The 50 is bottoming and will start moving up next week. The 100 day ma is still in a down trend, but we are right at it today.
0 · Reply
HarryPopotter
HarryPopotter Aug. 6 at 4:07 PM
$PFE https://www.change.org/p/keep-hope-alive-approve-deramiocel-children-with-dmd-are-dying
0 · Reply
Brice149
Brice149 Aug. 6 at 4:05 PM
$PFE Woould be great to close above 25.92. Would love higher but that would be above the 100 day average and 200 day average.
0 · Reply
Brice149
Brice149 Aug. 6 at 4:00 PM
$PFE Sitting right at the 200 day m/a
1 · Reply
Micheal_Pothead
Micheal_Pothead Aug. 6 at 3:38 PM
$PFE just go red
0 · Reply
BarkingPuppy
BarkingPuppy Aug. 6 at 3:07 PM
$ELTP $PFE $WEN Elite is ready to go.. Green baby green !!!!!!
1 · Reply
Brice149
Brice149 Aug. 6 at 3:05 PM
$PFE Day, Week, and Month charts all look good. Question for the group, can we get back to 27-30 level without some catalyst by year end?
0 · Reply
Brice149
Brice149 Aug. 6 at 3:02 PM
$PFE I ended up rolling my 26 options for this friday, to 26.5 for next friday. I was hoping for max pain.....but I chickened out. lol.
0 · Reply
pineconecameo
pineconecameo Aug. 6 at 2:52 PM
$PFE ♻️ we always liveee babyyyy
0 · Reply
Latest News on PFE
Pfizer’s (PFE) Q2 Earnings Support a Bullish View

2026-08-06T13:09:00.000Z - 3 hours ago

Pfizer’s (PFE) Q2 Earnings Support a Bullish View


Pfizer price target raised to $27 from $26 at BofA

2026-08-05T10:45:23.000Z - 1 day ago

Pfizer price target raised to $27 from $26 at BofA


Pfizer Earnings Call Transcript: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 2 days ago

Pfizer Earnings Call Transcript: Q2 2026


Pfizer Earnings release: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 2 days ago

Pfizer Earnings release: Q2 2026


Pfizer Slides: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 2 days ago

Pfizer Slides: Q2 2026


Pfizer Quarterly report: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 2 days ago

Pfizer Quarterly report: Q2 2026


Pfizer Post Loss on Higher Revenue

Aug 4, 2026, 7:24 AM EDT - 2 days ago

Pfizer Post Loss on Higher Revenue


Pfizer reports Q2 adjusted EPS 77c, consensus 68c

2026-08-04T10:52:17.000Z - 2 days ago

Pfizer reports Q2 adjusted EPS 77c, consensus 68c


Pfizer says LITFULO studies meet co-primary endpoints

2026-07-30T11:03:18.000Z - 7 days ago

Pfizer says LITFULO studies meet co-primary endpoints


FDA grants priority review for Pfizer’s Talzena plus Xtandi

2026-07-22T20:40:37.000Z - 14 days ago

FDA grants priority review for Pfizer’s Talzena plus Xtandi


Options Corner: PFE Downgrade, Stock Slides Near 52-Week Low

Jul 6, 2026, 10:00 AM EDT - 4 weeks ago

Options Corner: PFE Downgrade, Stock Slides Near 52-Week Low


Pfizer Declares Third-Quarter 2026 Dividend

Jun 24, 2026, 3:52 PM EDT - 6 weeks ago

Pfizer Declares Third-Quarter 2026 Dividend


Pfizer dismissed from US states' drug price-fixing lawsuit

Jun 24, 2026, 10:51 AM EDT - 6 weeks ago

Pfizer dismissed from US states' drug price-fixing lawsuit


Pfizer CFO Dave Denton to step down, leave company in August

Jun 18, 2026, 6:52 AM EDT - 7 weeks ago

Pfizer CFO Dave Denton to step down, leave company in August


Pfizer Announces Chief Financial Officer Transition

Jun 18, 2026, 6:45 AM EDT - 7 weeks ago

Pfizer Announces Chief Financial Officer Transition


US FDA approves Pfizer's bleeding disorder drug for children

Jun 8, 2026, 6:49 AM EDT - 2 months ago

US FDA approves Pfizer's bleeding disorder drug for children


Pfizer Transcript: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Transcript: Study update


Pfizer Slides: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Slides: Study update


Pfizer Press release: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Press release: Study update


Pfizer Transcript: Jefferies Global Healthcare Conference 2026

Jun 3, 2026, 2:00 PM EDT - 2 months ago

Pfizer Transcript: Jefferies Global Healthcare Conference 2026


TraderDaKing
TraderDaKing Aug. 6 at 4:49 PM
$ELTP $PFE $JNJ $MRNA $LLY Who is doing a deal with Elite?? SequestOx (ELI-200) is an investigational, abuse-deterrent opioid product developed by Elite Pharmaceuticals containing a combination of oxycodone hydrochloride and sequestered naltrexone for managing moderate to severe pain. How SequestOx WorksNormal Use: Taken orally as intended, the opioid agonist (oxycodone) releases for pain relief while the antagonist (naltrexone) stays locked inside and passes through the body unreleased.Tampering: If the capsule or beads are crushed, chewed, or dissolved, the naltrexone releases.Blockade: The released naltrexone blocks the euphoric high of oxycodone by binding to brain receptors, which deters recreational abuse. https://elitepharma.com/ Roaring Kitty?
0 · Reply
Brice149
Brice149 Aug. 6 at 4:26 PM
$PFE Lots of good if you look for it. The 20 and the 200 day ma are both moving up. The 50 is bottoming and will start moving up next week. The 100 day ma is still in a down trend, but we are right at it today.
0 · Reply
HarryPopotter
HarryPopotter Aug. 6 at 4:07 PM
$PFE https://www.change.org/p/keep-hope-alive-approve-deramiocel-children-with-dmd-are-dying
0 · Reply
Brice149
Brice149 Aug. 6 at 4:05 PM
$PFE Woould be great to close above 25.92. Would love higher but that would be above the 100 day average and 200 day average.
0 · Reply
Brice149
Brice149 Aug. 6 at 4:00 PM
$PFE Sitting right at the 200 day m/a
1 · Reply
Micheal_Pothead
Micheal_Pothead Aug. 6 at 3:38 PM
$PFE just go red
0 · Reply
BarkingPuppy
BarkingPuppy Aug. 6 at 3:07 PM
$ELTP $PFE $WEN Elite is ready to go.. Green baby green !!!!!!
1 · Reply
Brice149
Brice149 Aug. 6 at 3:05 PM
$PFE Day, Week, and Month charts all look good. Question for the group, can we get back to 27-30 level without some catalyst by year end?
0 · Reply
Brice149
Brice149 Aug. 6 at 3:02 PM
$PFE I ended up rolling my 26 options for this friday, to 26.5 for next friday. I was hoping for max pain.....but I chickened out. lol.
0 · Reply
pineconecameo
pineconecameo Aug. 6 at 2:52 PM
$PFE ♻️ we always liveee babyyyy
0 · Reply
STOCKPICKERTRADER
STOCKPICKERTRADER Aug. 6 at 2:45 PM
$PFE nice to see the start of more Insider Purchases for sure and want to see more continuing as their progress is going to become more visible over the weeks and months ahead! GLTAL
0 · Reply
doubleuptwice
doubleuptwice Aug. 6 at 2:38 PM
$PFE yeh couldn’t imagine selling this 4hr chart
0 · Reply
Micheal_Pothead
Micheal_Pothead Aug. 6 at 2:22 PM
$PFE POS as always
1 · Reply
CandlesBACKEDSECURITIES
CandlesBACKEDSECURITIES Aug. 6 at 2:05 PM
$PFE passive income porn 💃
0 · Reply
NorthOfSouth
NorthOfSouth Aug. 6 at 2:01 PM
$PFE Wen rug pull?
1 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 Aug. 6 at 1:59 PM
$PFE - How quaint
1 · Reply
nimii
nimii Aug. 6 at 1:38 PM
$PFE 😡😤
0 · Reply
IncelBull
IncelBull Aug. 6 at 1:36 PM
$LULU women and the LGBTQ community will be buying new yogapants as they are using GLP1s from $NVO and $PFE $LLY $AMGN
1 · Reply
GordoHLYK13
GordoHLYK13 Aug. 6 at 1:07 PM
$IGC 🚀 Bullish: 121K+ shares traded before the open—3.5x–4x normal pre-market volume and already 30–50% of a typical full day’s volume. That’s serious accumulation. If this momentum continues, a break above $0.26–$0.28 could quickly send IGC toward $0.30–$0.35. Maybe a little bird already knows something about the CALMA trial… 👀🐦 Time will tell, but this kind of unusual volume definitely has my attention. 📈 $PFE $MRNA
0 · Reply
CandlesBACKEDSECURITIES
CandlesBACKEDSECURITIES Aug. 6 at 12:57 PM
$PFE accumulation at ATL for a killer dividend -------------------
1 · Reply
CandlesBACKEDSECURITIES
CandlesBACKEDSECURITIES Aug. 6 at 12:56 PM
$PFE smart
0 · Reply
jrh34
jrh34 Aug. 6 at 12:32 PM
$CRDF If $AZN and $BMY were to combine as speculated that would create a $50B oncology therapy powerhouse, which would likely send $PFE shopping for something like $CRDF onvansertib as it would add a projected $3-5 Billion a year in mCRC alone. Could we be looking at 5-10x return from today's price?
0 · Reply